By upregulating the HO-1/Nrf2 pathway, the application of low molecular weight blue mussel hydrolysate impedes the differentiation of mouse mesenchymal stem cells into fat cells, thus improving the condition of obesity. The gene discussed is NFE2L2; the disease is obesity due to melanocortin 4 receptor deficiency.